|
1
|
Weiderpass E and Labreche F: Malignant
tumors of the female reproductive system. Saf Health Work.
3:166–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang CY, Lee CY, Chen MY, Yang WH, Chen
YH, Chang CH, Hsu HC, Fong YC and Tang CH: Stromal cell-derived
factor-1/CXCR4 enhanced motility of human osteosarcoma cells
involves MEK1/2, ERK and NF-kappaB-dependent pathways. J Cell
Physiol. 221:204–212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scotton CJ, Wilson JL, Milliken D, Stamp G
and Balkwill FR: Epithelial cancer cell migration: A role for
chemokine receptors? Cancer Res. 61:4961–4965. 2001.PubMed/NCBI
|
|
4
|
Chen Y, Stamatoyannopoulos G and Song CZ:
Down-regulation of CXCR4 by inducible small interfering RNA
inhibits breast cancer cell invasion in vitro. Cancer Res.
63:4801–4804. 2003.PubMed/NCBI
|
|
5
|
Chen HY, Wang JM, Wang HY, Zhang YX, Liu
W, Pan L, Wang WH, Chen SF, Jin WG and Wang L: Effect of short
hairpin RNA-induced CXCR4 silence on ovarian cancer cell. Biomed
Pharmacother. 66:549–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi KC, Auersperg N and Leung PC:
Mitogen-activated protein kinases in normal and (pre)neoplastic
ovarian surface epithelium. Reprod Biol Endocrinol. 1:712003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park J, Song KH and Ha H: Fractalkine
increases mesangial cell proliferation through reactive oxygen
species and mitogen-activated protein kinases. Transplant Proc.
44:1026–1028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang SH, Sharrocks AD and Whitmarsh AJ:
MAP kinase signalling cascades and transcriptional regulation.
Gene. 513:1–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Janku F, Wheler JJ, Westin SN, Moulder SL,
Naing A, Tsimberidou AM, Fu S, Falchook GS, Hong DS, Garrido-Laguna
I, et al: PI3K/AKT/mTOR inhibitors in patients with breast and
gynecologic malignancies harboring PIK3CA mutations. J Clin Oncol.
30:777–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayakawa J, Ohmichi M, Kurachi H, Ikegami
H, Kimura A, Matsuoka T, Jikihara H, Mercola D and Murata Y:
Inhibition of extracellular signal-regulated protein kinase or
c-Jun N-terminal protein kinase cascade, differentially activated
by cisplatin, sensitizes human ovarian cancer cell line. J Biol
Chem. 274:31648–31654. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshioka K: Scaffold proteins in mammalian
MAP kinase cascades. J Biochem. 135:657–661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao HB, Tang CL, Hou YL, Xue LR, Li MQ,
Du MR and Li DJ: CXCL12/CXCR4 axis triggers the activation of EGF
receptor and ERK signaling pathway in CsA-induced proliferation of
human trophoblast cells. PLoS One. 7:e383752012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vergara D, Simeone P, Toraldo D, Del
Boccio P, Vergaro V, Leporatti S, Pieragostino D, Tinelli A, De
Domenico S, Alberti S, et al: Resveratrol downregulates Akt/GSK and
ERK signalling pathways in OVCAR-3 ovarian cancer cells. Mol
Biosyst. 8:1078–1087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Porcile C, Bajetto A, Barbero S, Pirani P
and Schettini G: CXCR4 activation induces epidermal growth factor
receptor transactivation in an ovarian cancer cell line. Ann N Y
Acad Sci. 1030:162–169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen X, Wang S, Wang H, Liang M, Xiao L
and Wang Z: The role of SDF-1/CXCR4 axis in ovarian cancer
metastasis. J Huazhong Univ Sci Technolog Med Sci. 29:363–367.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tarcic G and Yarden Y: MAP Kinase
activation by receptor tyrosine kinases: In control of cell
migration. Methods Mol Biol. 661:125–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Komuro Y, Takeda K and Ichijo H:
Regulatiory mechanism of cell dealth through ASK1. Seikagaku.
76:1458–1462. 2004.(In Japanese). PubMed/NCBI
|
|
20
|
Matsuzawa A and Ichijo H: Redox control of
cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase
pathway in stress signaling. Biochim Biophys Acta. 1780:1325–1336.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hatai T, Matsuzawa A, Inoshita S, Mochida
Y, Kuroda T, Sakamaki K, Kuida K, Yonehara S, Ichijo H and Takeda
K: Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced
apoptosis by the mitochondria-dependent caspase activation. J Biol
Chem. 275:26576–26581. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo Y, Xu X, Liu Z, Zhang T, Zhang X, Wang
L, Wang M, Liu Y, Lu Y, Liu Y, et al: Apoptosis signal-regulating
kinase 1 is associated with the effect of claudin-6 in breast
cancer. Diagn Pathol. 7:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JT, Fong YC, Li TM, Liu JF, Hsu CW,
Chang CS and Tang CH: DDTD, an isoflavone derivative, induces cell
apoptosis through the reactive oxygen species/apoptosis
signal-regulating kinase 1 pathway in human osteosarcoma cells. Eur
J Pharmacol. 597:19–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu WS, Tian DS, Guo ZB, Fang J, Zhang Q,
Yu ZY, Xie MJ, Zhang HQ, Lu JG and Wang W: Inhibition of EGFR/MAPK
signaling reduces microglial inflammatory response and the
associated secondary damage in rats after spinal cord injury. J
Neuroinflammation. 9:1782012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhen YZ, Lin YJ, Gao JL, Zhao YF and Xu
AJ: Rhein lysinate inhibits cell growth by modulating various
mitogen-activated protein kinases in cervical cancer cells. Oncol
Lett. 2:129–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
